Evaluation Serum Chemerin and Visfatin Levels with Rheumatoid Arthritis: Possible Diagnostic Biomarkers
1. Yap H-Y, Tee SZ-Y, Wong MM-T, Chow S-K, Peh S-C, Teow S-Y. Pathogenic role of immune cells in rheumatoid arthritis: implications in clinical treatment and biomarker development. Cells. 2018;7(10):161.
2. Al-Rubaye AF, Kadhim MJ, Hameed IH. Rheumatoid Arthritis: History, Stages, Epidemiology, Pathogenesis, Diagnosis and Treatment. Int J Toxicol Pharmacol Res. 2017;9(2):145–55.
3. Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham III CO et al. 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum. 2010;62(9):2569–81.
4. Jakovljevi? B, Paunovi? K, Stojanov V. Adipose tissue as an endocrine organ. Srp Arh Celok Lek. 2005;133(9–10):441–5
5. Ouchi N, Parker JL, Lugus JJ, Walsh K. Adipokines in inflammation and metabolic disease. Nat Rev Immunol. 2011;11(2):85–97.
6. Giralt M, Cereijo R, Villarroya F. Adipokines and the endocrine role of adipose tissues. Metab Control. 2015;265–82.
7. Bonomini M, Pandolfi A. Chemerin in renal dysfunction and cardiovascular disease. Vascul Pharmacol. 2016;77:28–34.
8. Ernst MC, Haidl ID, Zúñiga LA, Dranse HJ, Rourke JL, Zabel BA, et al. Disruption of the chemokine-like receptor-1 (CMKLR1) gene is associated with reduced adiposity and glucose intolerance. Endocrinology. 2012;153(2):672–82.
9. Ha Y-J, Kang E-J, Song J-S, Park Y-B, Lee S-K, Choi ST. Plasma chemerin levels in rheumatoid arthritis are correlated with disease activity rather than obesity. Jt Bone Spine. 2013;81(2):189–90.
10. Fukuhara A, Matsuda M, Nishizawa M, Segawa K, Tanaka M, Kishimoto K, et al. Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science (80- ). 2005;307(5708):426–30.
11. Del Prete A, Salvi V, Sozzani S. Adipokines as potential biomarkers in rheumatoid arthritis. Mediators Inflamm. 2014;2014.
12. Jonsson MK, Sundlisæter NP, Nordal HH, Hammer HB, Aga A-B, Olsen IC, et al. Calprotectin as a marker of inflammation in patients with early rheumatoid arthritis. Ann Rheum Dis. 2017;76(12):2031–7.
13. Otero M, Logo R, Gomez R, Logo F, Dieguez C, Gómez-Reino JJ, et al. Changes in plasma levels of fat-derived hormones adiponectin, leptin, resistin and visfatin in patients with rheumatoid arthritis. Ann Rheum Dis. 2006;65(9):1198–201.
14. Ali DMM, Al-Fadhel SZ, Al-Ghuraibawi NHA, Al-Hakeim HK. Estimation of Serum Chemerin, Visfatin Levels and Their Ratio as A Possible Diagnostic Parameters of Rheumatoid Arthritis. 2019;
15. Ernst MC, Sinal CJ. Chemerin: at the crossroads of inflammation and obesity. Trends Endocrinol Metab. 2010;21(11):660–7.
16. Bozaoglu K, Curran JE, Stocker CJ, Zaibi MS, Segal D, Konstantopoulos N, et al. Chemerin, a novel adipokine in the regulation of angiogenesis. J Clin Endocrinol Metab. 2010;95(5):2476–85.
17. Fontes VS, Neves FS, Cândido APC. Chemerin and factors related to cardiovascular risk in children and adolescents: a systematic review. Rev Paul Pediatr. 2018;36:221–9.
18. Maghsoudi Z, Kelishadi R, Hosseinzadeh-Attar MJ. Association of chemerin levels with anthropometric indexes and C-reactive protein in obese and non-obese adolescents. ARYA Atheroscler. 2015;11(Suppl 1):102.
19. Lu B, Zhao M, Jiang W, Ma J, Yang C, Shao J, et al. Independent association of circulating level of chemerin with functional and early morphological vascular changes in newly diagnosed type 2 diabetic patients. Medicine (Baltimore). 2015;94(47).
20. Ali DMM, Al-Fadhel SZ, Al-Ghuraibawi NHA, Al-Hakeim HK. Serum chemerin and visfatin levels and their ratio as possible diagnostic parameters of rheumatoid arthritis. Reumatologia. 2020;58(2):67.
21. Alkady EAM, Ahmed HM, Tag L, Abdou MA. Serum and synovial adiponectin, resistin, and visfatin levels in rheumatoid arthritis patients. Z Rheumatol. 2011;70(7):602.
22. Sglunda O, Mann H, Hulejová H, Kuklová M, Pecha O, Pleštilová L, et al. Decreased circulating visfatin is associated with improved disease activity in early rheumatoid arthritis: data from the PERAC cohort. PLoS One. 2014;9(7):e103495.
23. Institutet K, Hambardzumyan K. Predictive Biomarkers in Rheumatoid Arthritis. 2018.
24. Arogbodo , J. O. ., Faluyi, O. B. ., &Igbe, F. O. . (2021). In vitro Antimicrobial Activity of Ethanolic Leaf Extracts of Hibiscus Asper Hook. F. and Hibiscus Sabdariffa L. on some Pathogenic Bacteria. Journal of Scientific Research in Medical and Biological Sciences, 2(3), 1-12. https://doi.org/10.47631/jsrmbs.v2i3.304
25. Brentano F, Schorr O, Ospelt C, Stanczyk J, Gay RE, Gay S, et al. Pre–B cell colony?enhancing factor/visfatin, a new marker of inflammation in rheumatoid arthritis with proinflammatory and matrix?degrading activities. Arthritis Rheum Off J Am Coll Rheumatol. 2007;56(9):2829–39.
26. Mirfeizi Z, Noubakht Z, Rezaie AE, Jokar MH, Sarabi ZS. Plasma levels of leptin and visfatin in rheumatoid arthritis patients; is there any relationship with joint damage? Iran J Basic Med Sci. 2014;17(9):662–27. Makhlouf, A.-M. A. ., Mahmoud, A. M. ., Ibrahim, R. G. ., & Abdel Aziz, Y. S. . (2021). Effects of Vitamin D and Simvastatin on Inflammatory and Oxidative Stress Markers of High-Fat Diet-Induced Obese Rats. Journal of Scientific Research in Medical and Biological Sciences, 2(3), 39-50. https://doi.org/10.47631/jsrmbs.v2i3.297